Rademikibart Treatment for Moderate-to-Severe Uncontrolled Asthma: A Phase 2B Randomized Clinical Trial

Journal:

American Journal of Respiratory and Critical Care Medicine

Published:

2025-05-01

DOI:

10.1164/rccm.202409-1708oc

Affiliations:

4

Authors:

11

Go to article

Institutions	Authors	Share
Connect Biopharma Holdings Ltd., United States of America (USA)	4.000000	0.36
National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, China	3.000000	0.27
Suzhou Connect Biopharmaceuticals, Ltd., China	3.000000	0.27
Allergy and Asthma Center of Southern Oregon, United States of America (USA)	1.000000	0.09

Interested in Immunology?